Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suninvest is a prominent Angolan private investment and holding company that plays a critical role in the nation's healthcare infrastructure. Through its joint venture with the Angolan Ministry of Health, known as Nova Angomédica, the company operates the primary pharmaceutical manufacturing facility in Angola. Suninvest focuses on the production of essential generic medicines, including antimalarials, analgesics, anti-inflammatories, and anti-tuberculosis drugs. The company's operations are central to Angola's efforts to reduce its reliance on imported pharmaceuticals and improve the availability of affordable treatments locally. Additionally, Suninvest maintains strategic collaborations with international partners like Laboratory Teuto Brasileiro to support its manufacturing standards and product range.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suninvest.